The QualityStocks Daily Friday, June 21st, 2024

Today's Top 3 Investment Newsletters

QualityStocks(AREB) $0.7600 +152.49%

Premium Stock Alerts(SPEC) $0.4900 +44.12%

Stocks to Buy Now(IGC) $0.5500 +36.61%

The QualityStocks Daily Stock List

American Rebel Holdings (AREB)

QualityStocks, MoneyTV, StockWireNews, StockStreetWire, MarketClub Analysis, Fierce Analyst, The Stock Dork, Small Caps, Small Cap Firm and InvestorPlace reported earlier on American Rebel Holdings (AREB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

American Rebel Holdings Inc. (NASDAQ: AREB) is focused on the provision of personal security products.

The firm has its headquarters in Nashville, Kansas and was incorporated in 2014, December 15th. The firm serves consumers in the United States.

The company is focused on promoting responsible gun ownership while celebrating a concealed carry lifestyle and providing innovative products.

The enterprise provides vault doors, as well as personal, office and home safes. Its American Rebel Safes are among the most desirable residential safes on the market. Its Black Smoke safes are specifically designed to meet the needs of gun aficionados and home owners and come in half a dozen different sizes. The enterprise also offers concealed carry backpacks; and a range of concealed carry vests, hats, backpacks, CDs, jackets, T-shirts and coats for women and men. It uses its proprietary CCW gear, Protection Pocket, to keep consumers safe and concealed while offering easy and quick access to their firearms. In addition to this, the enterprise also offers supplemental accessories, which include space savings items for safes, like moisture guard, light kits, hangers and rifle rod kits. It markets its products online, as well as through hunting, local specialty sports, retailers and firearms stores.

The company is focused on expanding its reach and growing its visibility within America by entering into dealership agreements with different brands. This will grow its consumer reach and bring in additional revenue into the company while boosting its growth, which will greatly benefit its shareholders.

American Rebel Holdings (AREB), closed Friday's trading session at $0.76, up 152.4917%, on 371,719,192 volume. The average volume for the last 3 months is 969,230 and the stock's 52-week low/high is $0.2111/$6.49.

GeoVax Labs (GOVX)

Wall Street Resources, QualityStocks, IRGnews Alert, Standout Stocks, MarketClub Analysis, MarketBeat, Penny Performers, BUYINS.NET, InvestorPlace, SmallCapStockPlays, SmallCapVoice, Stock News Now, Stock Stars, Stockpalooza, Premium Stock Alerts, INO Market Report, FeedBlitz, DrStockPick, M2 Communications, Daily Market Beat, CoolPennyStocks, HotOTC, Money Wealth Matters, PennyOmega, PoliticsAndMyPortfolio, Prism MarketView, ProActive Capital, Schaeffer's, The Online Investor, The Street, TradersPro, Wall Street Mover and PennyTrader.com reported earlier on GeoVax Labs (GOVX), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

GeoVax Labs Inc. (NASDAQ: GOVX) (FRA: E8L) is a clinical stage biotechnology firm which is engaged in the development, manufacture, testing, licensing and commercialization of human vaccines that prevent and fight ailments caused by HIV-1 and other infectious agents.

The firm operates as part of the biotechnology research services industry and has its headquarters in Smyrna, Georgia. The company was founded in 1988 by Donald G. Hildebrand and Harriet Latham Robinson.

This firm is party to partnership and collaboration agreements with Leidos Inc., the University of California, the Geneva Foundation, Viamune Inc., American Gene Technologies International Inc., the Burnet Institute, the Scripps Research Institute, the University of Maryland Institute of Human Virology, University of Texas Medical Branch, Georgia State University Research Foundation, University of Pittsburgh, Emory University, U.S. Naval Research Laboratory, U.S. Army Research Institute of Infectious Disease, U.S. Department of Defense, the CDC, the HIV Vaccines Trial Network and the National Institute of Allergy and Infectious Diseases of the NIH.

The company is currently developing preventive vaccines against malaria, Zika virus, HIV and the coronavirus as well as hemorrhagic fever viruses like Lassa, Marburg and Ebola; and therapeutic vaccines for chronic Hepatitis B infections and HIV. Additionally, the firm is developing immunotherapies for solid tumor cancers.

This biotechnology firm is at the forefront of forward-thinking vaccine science. Its clinical success has improved its financial position as well its capital structure, which allows it secure long-term funding. Many expect the company to reach numerous vaccine development milestones over the next year, which will benefit both the firm and its shareholders.

GeoVax Labs (GOVX), closed Friday's trading session at $2.33, up 23.2804%, on 10,490,698 volume. The average volume for the last 3 months is 6.953M and the stock's 52-week low/high is $1.0901/$10.2405.

Clover Health Investments (CLOV)

Schaeffer's, InvestorPlace, MarketClub Analysis, StockEarnings, StocksEarning, Trades Of The Day, MarketBeat, The Online Investor, QualityStocks, The Street, CNBC Breaking News, Daily Trade Alert, BUYINS.NET, INO Market Report, InsiderTrades, Kiplinger Today, 360 Wall Street, PennyStockProphet, PennyStockScholar, Profitable Trader Authority and OTCtipReporter reported earlier on Clover Health Investments (CLOV), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Clover Health Investments Corp. (NASDAQ: CLOV) is engaged in the provision of healthcare insurance services. It operates as a Medicare Advantage insurer in the U.S.

The firm is based in Franklin, Tennessee and was incorporated in 2012. It serves consumers in the United States and offers private, medical and hospital insurance services. The firm has offices in Hong Kong, Nashville, Jersey City and San Francisco and was known as Capital Hedosophia Holdings Corp II before changing its name.

Their mission is to improve every life, which is why the firm works with its members and their doctors. To ensure that their goals are fully aligned with the health needs of their members, the company proactively identifies at risk members and teams up with their physicians to improve their health outcomes while simultaneously decreasing avoidable costs and accelerating care coordination. To do this, it uses its proprietary technology platform to collect, structure and examine behavioral and health data.

The firm provides a software platform known as Clover Assistant, which offers seniors in America with a Health Maintenance Organization and Preferred Provider Organization plans. The Clover Assistant offers personalized care recommendations and information to primary care physicians to help in clinical decision-making.

The company’s Clover Assistant helps keep medical costs low, which includes beneficiaries’ out-of-pocket costs. Additionally, it recently launched its IPO, with the number of investors expected to grow as more time goes by. Their product portfolio may also expand soon, which will bring in more investments.

Clover Health Investments (CLOV), closed Friday's trading session at $1.25, up 21.3592%, on 24,606,705 volume. The average volume for the last 3 months is 11,339 and the stock's 52-week low/high is $0.606/$1.63.

Oliveda International (OLVI)

QualityStocks, StocksEarning, StockHideout, Stock Guru, ProTrader, Stock Commander, KingPennyStocks, Penny Stock 101, Penny Stock General, PennyStockLocks, BullFreak, Small Cap Firm, Winston Small Cap, StockRockandRoll, StockRunway, StockTradingNetwork and Shiznit Stocks reported earlier on Oliveda International (OLVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Oliveda International Inc. (OTC: OLVI) is a leading global natural cosmetic company focused on manufacturing and distributing cosmetic and holistic products built around the pure essence of the olive tree and its oils.

The firm has its headquarters in Santa Monica, California and was incorporated in 1987, on May 5th by Thomas Lommel, a German real estate investor. It operates as part of the household and personal products industry, under the consumer defensive sector. The firm serves consumers around the globe.

The company is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinosde Leó, Spain. Its wholly-owned second-tier subsidiary, Oliveda DeutschlandGmbH, operates flagship stores, Olive Tree Pharmacy, in Dusseldorf and Berlin with plans to open new locations in Seoul, Los Angeles and Taipei. Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next 5 years.

The enterprise’s product lines include serums, facial washes, eye care products, and facial oils. Its body line of products includes body oils, washes, hand and foot care products along with other bathing products. Its holistic products include products based upon the wholesome essence of extra virgin olive oil, with mouth drawing oils, Orac and CamuCamu concentrate, Hydroxytyrosol Molecule, Tea Olive Matcha, and other products that have been shown to help the body perform more efficiently, and hair products include both shampoo and conditioners which are foremost in the industry.

The company recently announced new products in its waterless beauty lines, a move that may help better meet consumer needs while also bringing in additional revenues into the company.

Oliveda International (OLVI), closed Friday's trading session at $4.5, up 18.4211%, on 22,983 volume. The average volume for the last 3 months is 136,627 and the stock's 52-week low/high is $0.035/$8.50.

Medicenna Therapeutics Corp. (MDNAF)

QualityStocks and TradersPro reported earlier on Medicenna Therapeutics Corp. (MDNAF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company based in Toronto, Ontario. It focuses on oncology and the development and commercialization of novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first in class Empowered Cytokines™ (ECs) for the treatment of a wide array of cancers. Medicenna Therapeutics lists on the OTC Markets Group’s OTCQB.

Medicenna Therapeutics is developing an innovative set of tunable Superkines™, which can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming healthy cells.

Supported by a US$14.1M non-dilutive grant from CPRIT (Cancer Prevention and Research Institute of Texas), Medicenna Therapeutics’ lead IL4-EC, MDNA55, has completed enrolling patients in a Phase 2b clinical trial for rGBM, the most common and uniformly fatal form of brain cancer, at top-ranked brain cancer centers in the United States. MDNA55 has been studied in five clinical trials involving 132 patients. This includes 112 adults with rGBM.

MDNA55 has demonstrated compelling efficacy. Moreover, it has obtained Fast-Track and Orphan Drug status from the FDA (Food and Drug Administration) and FDA/EMA (European Medicines Agency) respectively. MDNA55 targets Temodar-resistant tumors. Delivery by CED infusion of MDNA55 bypasses the BBB (Blood Brain Barrier). Precision delivery achieves high doses without systemic exposure.

Medicenna also develops MDNA57 for solid tumors and on-malignant cells of the tumor micro-environment; and MDNA109, an IL-2 agonist to treat cancer immunotherapies. The Company also develops MDNA209, an IL-2 antagonist for autoimmune diseases; and MDNA413, a dual IL-4/IL-13 antagonist for the treatment of solid tumors, atopic dermatitis, asthma, and fibrosis. Furthermore, Medicenna develops MDNA132, an IL-13 agonist to treat solid tumors, and IL 13Ralpha2 chimeric antigen receptor T cell.

Medicenna Therapeutics Corp. (MDNAF), closed Friday's trading session at $1.41, up 16.5289%, on 227,271 volume. The average volume for the last 3 months is 109,232 and the stock's 52-week low/high is $0.151251/$2.20.

LakeShore Biopharma (LSB)

We reported earlier on LakeShore Biopharma (LSB), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

LakeShore Biopharma Company Limited (NASDAQ: LSB) (NASDAQ: LSBPW) (FRA: H6Z) is a global biopharmaceutical firm focused on the discovery, development, manufacture, and commercialization of vaccines and therapeutic biologics for infectious illnesses and cancer.

The firm has its headquarters in Beijing, China and was incorporated in 2002 by Yi Zhang. Prior to its name change in May 2024, the firm was known as YS Biopharma Company Limited. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe, with a focus on those in Singapore, the People’s Republic of China, the Philippines, the United States, and the United Arab Emirates. It has more than 800 employees who are led by a management team that combines rich local expertise and global vision in the vaccine and pharmaceutical industry.

The enterprise's vaccine product YSJATM for rabies has been commercialized. It also has 4 product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HPV, influenza and cancer with enormous medical demand. In addition to this, the enterprise is working on a series of therapeutic targets, rabies and products at the discovery stage.

The company recently changed its name to align with its global brand image and market positioning. It remains focused on expanding its market reach and driving success under its new name. This may, in turn, open it up to new growth and investment opportunities while also creating additional value for its shareholders.

LakeShore Biopharma (LSB), closed Friday's trading session at $0.6, up 2.5641%, on 44,042 volume. The average volume for the last 3 months is 4.608M and the stock's 52-week low/high is $0.3503/$1.75.

Zoomcar Holdings (ZCAR)

FreeRealTime, Premium Stock Alerts and 360 Wall Street reported earlier on Zoomcar Holdings (ZCAR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Zoomcar Holdings (NASDAQ: ZCAR), a marketplace for car sharing in emerging markets, recently announced the closing of a private placement. According to the announcement, the company closed the purchase and sale of approximately $3.6 million of promissory notes and investor warrants for expected aggregate gross proceeds of $3 million with institutional investors. The private placement consisted of the sale of senior non-convertible notes in an aggregate principal amount of $3,600,000 and warrants to purchase approximately 53 million shares of company common stock with an exercise price of $0.1416 per unit. The notes, issued at an original issue discount of approximately 16.67%, will bear interest at 15% per year unless an event of default has occurred, upon which interest accrues at 20% per year. The warrants are exercisable beginning on the later of (a) the six-month anniversary of issuance and (b) the date the company’s stockholders provide approval. Zoomcar intends to use the net proceeds from the offering, together with its existing cash, for general corporate purposes and working capital. Aegis Capital Corp. acted as the exclusive placement agent for the private placement.

To view the full press release, visit https://ibn.fm/IuHsI

About Zoomcar Holdings Inc.

Founded in 2013 and headquartered in Bengaluru, India, Zoomcar is a marketplace for car sharing focused on emerging markets. The Zoomcar community connects Hosts with guests, who choose from a selection of cars for use at affordable prices, promoting sustainable, smart transportation solutions in growing markets. For more information, please visit www.zoomcar.com

Zoomcar Holdings (ZCAR), closed Friday's trading session at $0.1507, up 3.078%, on 48,721,246 volume. The average volume for the last 3 months is 26.169M and the stock's 52-week low/high is $0.13/$14.75.

Snap (SNAP)

Schaeffer's, InvestorPlace, The Street, MarketClub Analysis, MarketBeat, StockEarnings, StocksEarning, Trades Of The Day, Kiplinger Today, StreetInsider, Zacks, Daily Trade Alert, Market Intelligence Center Alert, INO Market Report, The Online Investor, Investopedia, Wealth Insider Alert, CNBC Breaking News, Early Bird, Barchart, The Street Report, Marketbeat.com, StockMarketWatch, Trading Concepts, StreetAuthority Daily, Profit Confidential, Louis Navellier, QualityStocks, Top Pros' Top Picks, Market Intelligence Center, TopStockAnalysts, Money Morning, Jon Markman’s Pivotal Point, AllPennyStocks, GorillaTrades, Investors Alley, FreeRealTime, Daily Profit, Total Wealth, MarketTamer, InvestmentHouse, 24/7 Trader, Trading Tips, TipRanks, Investment House, Cabot Wealth, The Wealth Report, Uncommon Wisdom, Investiv, Investing Daily, Investment U, wyatt research newsletter, Wall Street Window, StockGuru, Daily Wealth, Rick Saddler, MarketWatch, Dynamic Wealth Report, Economy & Markets, Energy & Resources Digest, Max Wealth, SmallCap Network, Direction Alerts, BUYINS.NET, Epic Stock Picks, 360 Wall Street, Prism MarketView, Wealth Week, Wealth Daily, Wall Street Profit Search, Wall Street Daily, Technology Profits Daily, StrategicTechInvestor, StockRockandRoll, Schaeffer’s, Money and Markets, ProfitableTrading, InvestorsObserver Team, Power Profit Trades, PennyStockLocks, Penny Stock 101, Penny Picks, OTC Stock Review, newmoneycrew, MarketClub, Jon Markman's Pivotal Point, InvestorsUnderground and Promotion Stock Secrets reported earlier on Snap (SNAP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Snap (NYSE: SNAP), the parent company behind the popular social media platform Snapchat, has recently made headlines with its innovative leap into generative artificial intelligence (“AI”) tools for augmented reality (“AR”) effects. This move is a testament to Snap’s commitment to enhancing digital interaction through AR, a technology that CEO Evan Spiegel regards as a transformative force in computing. By integrating AI into their AR capabilities, Snap aims to streamline the creative process for artists and developers, reducing the time required to create AR effects from weeks to mere hours.

The financial implications of Snap’s advancements in AI and AR technologies are evident in their recent quarterly report. The company reported a revenue of approximately $1.19 billion, with a gross profit of roughly $580.46 million. Despite these strong revenue figures, Snap faced challenges, as indicated by significant operating expenses of about $913.69 million and a negative operating profit margin of approximately -28.39%. These figures highlight the financial pressures Snap faces as it invests heavily in innovative technologies to stay ahead in the competitive social media landscape.

Snap’s investment in AI and AR not only aims to enhance user experience but also serves as a strategic move to attract advertisers by offering immersive shopping experiences and virtual try-ons. This approach is crucial for Snap’s monetization strategy, as it seeks to leverage AI, ML, and AR features to drive immediate purchases through the platform. The company’s focus on these technologies is a response to the growing demand for interactive and personalized online shopping experiences, which have become increasingly important in bridging the trust gap for online shoppers.

The efficiency at which Snap utilizes its assets to generate sales is reflected in its asset turnover ratio of 0.67 for the trailing twelve months (“TTM”). However, the lack of an inventory turnover ratio suggests that Snap’s business model does not rely on inventory-based operations, which is consistent with its focus on digital products and services. The substantial investment in physical assets, with a net value of about $937.48 million in property, plant, and equipment, underscores Snap’s commitment to supporting its innovative technologies.

As Snap continues to push the boundaries of what is possible with AI and AR in the digital space, its financial performance will be closely watched by investors and industry observers alike. The company’s efforts to streamline AR content creation and enhance digital interactions through innovative technologies are pivotal in maintaining its competitive edge. However, the financial challenges highlighted in its recent quarterly report underscore the importance of balancing innovation with profitability in the fast-evolving tech landscape.

To view the company’s most recent earnings release, visit https://ibn.fm/HWec8

About Snap Inc.

Snap Inc. is a technology company. We believe the camera presents the greatest opportunity to improve the way people live and communicate. We contribute to human progress by empowering people to express themselves, live in the moment, learn about the world, and have fun together. For more information, visit the company’s website at www.Snap.com.

Snap (SNAP), closed Friday's trading session at $15.51, up 0.7797271%, on 27,673,879 volume. The average volume for the last 3 months is 9.28M and the stock's 52-week low/high is $8.28/$17.90.

Canaan Inc. (CAN)

QualityStocks, MarketClub Analysis, Schaeffer's, StockEarnings, InvestorPlace, TradersPro, CryptoCurrencyWire, AllPennyStocks, MarketBeat, Stockhouse, StreetInsider, The Online Investor, INO Market Report, Early Bird, InvestorsUnderground, BUYINS.NET, Stock Fortune Teller, Trades Of The Day, StockMarketWatch, StocksEarning, The Street, TopStockAnalysts and SmarTrend Newsletters reported earlier on Canaan Inc. (CAN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

There is speculation among crypto enthusiasts that Donald Trump is aiming to win over the $2.5 trillion industry with a new digital token dubbed “Trump Coin” as he steps up his campaign for the upcoming November election. Industry analysts are investigating the origins of a meme token listed on the Solana blockchain under the symbol “DJT” and named “Trump Coin.”

DJT is associated with Trump’s social media platform, Truth Social, a stock market favorite since its IPO in March, reaching highs of $79.38 per share and now trading around $35.

Meme tokens, as with meme stocks, are influenced by internet culture and trends. Dogecoin and Shiba Inu, for example, started as jokes but grew into significant market players, pushing the meme coin market cap to about $50 billion. Trump Coin joins other meme tokens such as Dogwifhat, linked to a dog meme; Mother Iggy, a coin by rapper Iggy Azalea; and Jeo Boden, a satire on President Joseph Biden.

SolScan, a blockchain explorer, shows Trump Coin began trading on Solana recently, with a current market cap of $73 million.

Although it’s unclear if Trump directly supports the token, industry sources suggest associates of the former president have been working on a digital currency for a couple of months. Neither the Trump campaign nor Truth Social responded to requests for comments.

Trump Coin is one of several politically inspired meme tokens emerging this election season. Other unaffiliated Trump meme tokens include one under the MAGA symbol, featuring Trump’s slogan Make America Great Again, and a cartoon image of him with the American flag. The coin, trading at more than $9 with a market cap exceeding $400 million, saw its price dip with the news of Trump Coin’s launch.

Another Trump-oriented meme token, TROG, features a frog in a MAGA hat and has a market cap of $7.38 million, which also dropped following the Trump Coin announcement. TROG and MAGA are not formally associated with Trump or his 2024 campaign. But according to Arkham Intelligence, Trump has received a sizable quantity of MAGA and TROG tokens as gifts from the companies that created them.

Despite not being a typical crypto enthusiast, Trump has recognized the industry’s potential for voter support as the election approaches.

A study by Coinbase reveals that around 52 million U.S. citizens have used cryptocurrency, with this group becoming increasingly active in politics, supporting cryptofriendly candidates. One such contender is Republican crypto attorney John Deaton, who is challenging Massachusetts Democratic Senator Elizabeth Warren, a fierce opponent of cryptocurrency.

Analysts believe the cryptocurrency vote could be crucial in the upcoming election, with many in the industry identifying as single-issue voters focused on crypto policies. Trump aims to attract these voters with the assistance of experts such as entrepreneur and cryptocurrency supporter Ramaswamy, who has been guiding him on crypto-asset policies.

Industry players such as Canaan Inc. (NASDAQ: CAN) will be watching how crypto shapes the ongoing campaigns and upcoming elections as this could help policymakers come up with a clear regulatory direction for the industry.

Canaan Inc. (CAN), closed Friday's trading session at $1.11, off by 2.6316%, on 20,259,922 volume. The average volume for the last 3 months is 53.506M and the stock's 52-week low/high is $0.75/$3.50.

Nio Inc. (NIO)

Green Car Stocks, InvestorPlace, Schaeffer's, MarketClub Analysis, The Street, StocksEarning, MarketBeat, StockEarnings, QualityStocks, Daily Trade Alert, Kiplinger Today, Trades Of The Day, The Online Investor, Early Bird, INO Market Report, Zacks, StreetInsider, StockMarketWatch, BUYINS.NET, FreeRealTime, Cabot Wealth, GreenCarStocks, Money Wealth Matters, TipRanks, Wealth Insider Alert, AllPennyStocks, Earnings360, The Wealth Report, InvestorsUnderground, CNBC Breaking News, Daily Wealth, TradersPro, wyatt research newsletter, Louis Navellier, Investopedia, BillionDollarClub, Investors Underground, Energy and Capital, CRWEWallStreet, DividendStocks, Green Energy Stocks, InvestorIntel, Investors Alley, InvestorsObserver Team, Jim Cramer, MarketClub, TopPennyStockMovers, Top Pros’ Top Picks, Smartmoneytrading, Stock Market Watch, Top Pros' Top Picks, The Night Owl and Wealth Daily reported earlier on Nio Inc. (NIO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

In a move that has caught a lot of people, particularly investors and market analysts, off-guard, Electron Capital Partners LLC has significantly increased its stake in Nio, a Chinese electric vehicle manufacturer. This move has raised many questions about Nio Inc. (NYSE: NIO)‘s future growth prospects, its potential to revolutionize the electric vehicle industry and what the decision means for Electron Capital.

The company, which was founded in 2014, has grown to be a major player in the EV industry. Sometimes referred to as the Tesla of China, Nio has achieved a lot in less than the decade since it was founded, in some respects surpassing even the great companies such as China’s BYD.

Nio’s success is attributed to the battery-as-a-service (BaaS) model, where customers purchase an electric vehicle without batteries, thus reducing the cost of the car. Instead, the company allows users to subscribe to a solution to swap a depleted battery for a full one.  This flexible and convenient solution for electric vehicle owners has made EVs accessible and affordable for many people.

Additionally, this strategy has attracted the attention of many investors, including Baillie Gifford, who holds a significant stake in the company.

Details of the Stake Increase

As Electron Capital ups its stake in the company known for its smart vehicles integrating connectivity, AI and autonomous driving technologies, it has significantly increased its holdings. According to industry experts, this move has increased the vote of confidence in Nio’s prospects. However, there hasn’t been any official reporting on the transaction from Electron Capital or Nio.

The increased stake in Nio is attributed to several factors. First, Nio’s growth trajectory is looking up. The company’s position in the rapidly expanding EV market makes it a great investment. The EV industry is experiencing rapid growth, with demand for electric vehicles rising daily as governments worldwide impose stricter emissions regulations and incentivize EV adoption. Industry experts are confident that this demand will keep increasing. Consequently, Nio is well-positioned to capitalize on this trend with its innovative approach and commitment to quality and performance.

Secondly, Nio’s focus on battery and autonomous driving technology aligns with Electron Capital’s investment goals. Thirdly, the Chinese EV maker has established a strong market position despite the increased competition.

Overall, Electron Capital’s investment in Nio aligns with its broader technological and sustainable advancements strategy. So, by making this move, Electron Capital is positioning itself to reap big from the anticipated growth in the EV sector.

Nio Inc. (NIO), closed Friday's trading session at $4.3, off by 0.6928406%, on 22,036,714 volume. The average volume for the last 3 months is 868,724 and the stock's 52-week low/high is $3.61/$16.18.

Workhorse Group Inc. (WKHS)

Green Car Stocks, InvestorPlace, MarketClub Analysis, QualityStocks, Schaeffer's, Kiplinger Today, StocksEarning, MarketBeat, StockMarketWatch, StockEarnings, TradersPro, StreetInsider, Early Bird, The Street, Trades Of The Day, GreenCarStocks, The Online Investor, Daily Trade Alert, TopPennyStockMovers, TraderPower, BUYINS.NET, Wealth Insider Alert, Money Wealth Matters, Zacks, StockOodles, Marketbeat.com, Cabot Wealth, Jason Bond, InvestorsUnderground, PoliticsAndMyPortfolio, The Night Owl, Daily Market Beat, The Wealth Report, Energy and Capital, Wealth Daily, Profitable Trader Authority, Stock Beast and The Best Newsletters reported earlier on Workhorse Group Inc. (WKHS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Secondhand electric vehicle prices have maintained their downward trend several weeks after they first fell; they are now costing customers several thousand dollars less compared to similar vehicles with internal combustion engines. For drivers who were interested in switching to battery electric vehicles (BEVs) but were held back by prices, this represents the best time to finally ditch their fossil-fuel powered vehicles and replace them with BEVs.

A recent analysis published by iSeeCars has revealed that with the price difference between the BMW 3 Series and a secondhand Tesla Model 3 shrinking rapidly, the premium that has been associated with electric cars for the past decade has been all but erased. A small percentage of customers, particularly the early adopter market, were more than willing to pay this premium when electric vehicles first launched, but top EV makers such as Tesla are now struggling to attract customers who can shell out tens of thousands to own an electric car.

Consequently, the recent fall in used electric vehicle prices has significantly increased the potential for first time electric vehicle owners across several major markets. The fall in battery electric vehicle prices began in February when used EVs  became cheaper than used ICE cars for the first time since electric cars hit the mass market. As Tesla and other top electric vehicle makers cut new electric vehicle prices amid an intense price discount war, used electric vehicle prices declined dramatically.

Compared to last June when the average used electric vehicle cost 25% more than secondhand gas-powered cars, used EVs were 8% cheaper than comparable fossil fuel-powered cars by May 2024. While used petrol and diesel car prices have fallen by around 3%–7% over the last 12 months, used EV prices have declined by a whopping 30%–39%.  The gap between used electric vehicle and gas-powered vehicle prices has also extended to luxury brands, with secondhand BMW prices surpassing prices for comparable battery electric vehicles from Tesla by a “significant amount.”

iSeeCars executive analyst Karl Brauer noted in a recent iSeeCars report that secondhand vehicle shoppers have made it clear that they aren’t willing to pay premium prices for battery EVs anymore. The use of electricity is now a “detractor” rather than an attraction for many consumers, Brauer said, making battery electric cars less valuable and desirable to secondhand vehicle customers.

Despite the continuing fall in used-EV prices, a growing number of electric vehicle drivers are selling their used electric cars due to the growing market. The secondhand EV market currently has more electric cars than the new EV market, meaning significantly more drivers can now purchase an EV without having to break the bank.

As more innovation is implemented within the EV space, the new models from enterprises such as Workhorse Group Inc. (NASDAQ: WKHS) are bound to become more affordable, further driving down the prices in the used electric vehicle market.

Workhorse Group Inc. (WKHS), closed Friday's trading session at $1.71, up 0.5882353%, on 789,495 volume. The average volume for the last 3 months is 19.598M and the stock's 52-week low/high is $1.64/$27.20.

Alphabet Inc. (GOOG)

FreeRealTime, InvestorPlace, The Street, The Online Investor, StreetAuthority Daily, TopStockAnalysts, Money Morning, StreetInsider, Investopedia, IT News Daily, InvestorGuide, Daily Trade Alert, internetnews, The Motley Fool, Schaeffer's, Trades Of The Day, PROFIT CONFIDENTIAL, Street Insider, Kiplinger Today, Investor Guide, ProfitableTrading, MarketWatch, StocksEarning, internet, Wyatt Investment Research, Uncommon Wisdom, Barchart, MarketClub Analysis, Dividend Opportunities, Wealth Daily, MarketBeat, SiliconValley, All about trends, Wealth Insider Alert, Early Bird, Louis Navellier, Daily Profit, CustomerService, SmarTrend Newsletters, Cabot Wealth, TradingAuthority Daily, GorillaTrades, Total Wealth, Trading Markets, Investors Alley, Daily Wealth, The Wealth Report, Investment U, Energy and Capital, iStockAnalyst, Marketbeat.com, WStreet Market Commentary, Money and Markets, Investing Daily, Wall Street Daily, INO.com Market Report, The Street Report, BullDogReporter, SwingTradeOnline, InvestmentHouse, FeedBlitz, Daily Markets, Dynamic Wealth Report, SmallCap Network, Greenbackers, Shah's Insights & Indictments, Investment House, TradingMarkets, Options Elite, Insider Wealth Alert, Investor Update, Stock Gumshoe, Forbes, The Best Newsletters, Zacks, FNNO Newsletters, StockEarnings, Trade of the Week, INO Market Report, Market Authority, TheStockAdvisor, Penny Stock Buzz, The Growth Stock Wire, Inside Investing Daily, Darwin Investing Network, Eagle Financial Publications, Market Intelligence Center Alert, Top Pros' Top Picks, The Trading Report, StockTwits, StrategicTechInvestor, ChartAdvisor, The Tycoon Report, SureMoney, Super Stock Investor, Stock Up Featured, VectorVest, Money Wealth Matters, TipRanks, TheStockAdvisors, Market Wrap Daily, MarketTamer, QualityStocks, InsidersLab, Trading Tips, equities Canada, Stockhouse, Stock Analyzer, Visual Capitalist, Investiv, StreetAlerts, Equities.com, Wall Street Greek, Weekly Wizards, Investing Futures, Agora Financial, InsiderTrades, TradersPro, Penny Sleuth, Wallstreetlivechat, Daily Dividends, MarketArmor.com, Daily Market Beat, Investing Signal, Alternative Energy, StockMarketWatch, Short Term Wealth, Stocks To Watch, SmallCapNetwork, Google Alerts, Stock Research Newsletter, Coattail Investor, Terry's Tips, Smartmoneytrading, Trader Prep, Investment Contrarians, The Stock Enthusiast, The Wall Street Transcript, Power Profit Trades, The Weekly Options Trader, 777 Stocks, TopPennyStockMovers, Wealthpire Inc., Market Traders Institute, OptionAlarm News, 24/7 Trader, StreetAuthority Financial, Laissez Faire Today, Lebed.biz, Millennium-Traders, YOLOTraderAlerts, TradingPub, Market Trends, Taipan Daily, AllPennyStocks, PennyOmega and Quant Ratings Team reported earlier on Alphabet Inc. (GOOG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recently published report has highlighted concerns on the increased use of artificial intelligence in misinformation and the production of news. The report was published by the Reuters Institute for the Study of Journalism and provides a picture of the challenges newsrooms are already facing as they work to engage more individuals worldwide.

Globally, generative artificial intelligence is helping tech giants and start-ups such as Google and OpenAI develop tools that can divert traffic from news sites and provide short summaries of information. While this works against newsrooms and would suggest that consumers are in favor of AI use, the report determined that many were, in fact, suspicious of artificial intelligence’s use in generating news content, especially for sensitive topics.

According to the survey, 63% and 52% of respondents from the United Kingdom and the United States respectively stated that they would be uncomfortable with news produced primarily by artificial intelligence. The report also highlighted that most respondents were more comfortable with artificial intelligence being used in the background to make the work journalists did more efficient.

The lead author of the report, Nic Newman, stated that the researchers were surprised by the suspicion levels they observed. Newman, who is also a senior research associate at the institute, added that individuals’ fears mainly centered on what could happen to trust and reliability of journalistic content.

The study also reported that 59% of U.K. respondents admitted to being worried about the increase in false content online, with the report noting that this figure was even higher in the United States and South Africa, at 72% and 81% respectively.

Another problem mainstream media is grappling with is audiences’ unwillingness to pay for online news. The report determined that only 17% of those who took part in the survey across 20 nations paid for news subscriptions. This figure, which increased slightly during the pandemic, has remained stagnant these last three years.

The report also found that a considerable proportion of those who subscribed to news in America were likely to be paying discounted amounts because of promotions or trials, with more than 45% of them paying less than the full rate for their subscriptions. It doesn’t help that these days, news influencers play a significant role in delivering news to individuals on well-known platforms such as TikTok, in comparison to mainstream media.

In a poll involving nearly 6,000 TikTok users who revealed that they used the app to get news, 57% of them admitted to following individual personalities rather than news brands or journalists.

Entities that have interests in AI and the dissemination of news, such as Alphabet Inc. (NASDAQ: GOOGL) (NASDAQ: GOOG), need to think critically about the findings of this report and identify ways to win the confidence of people around the world because it appears AI-generated news isn’t inspiring trust.

Alphabet Inc. (GOOG), closed Friday's trading session at $180.26, up 1.4349%, on 59,728,019 volume. The average volume for the last 3 months is 3.405M and the stock's 52-week low/high is $115.83/$182.5117.

The QualityStocks Company Corner

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software and services, and the world's first commercial supplier of quantum computers, has announced the planned placement of the second U.S.-based D-Wave Advantage quantum computer. According to the announcement, the D-Wave Advantage system will be located at Davidson Technologies' new global headquarters in Huntsville, Alabama and could be the first in the United States that is certified for sensitive applications using annealing quantum computing. It is anticipated that the system could advance quantum's role in national security and support the critical mission of defending the United States and its allies, both at home and abroad.

"Davidson has a track record of embracing emerging and advanced technologies to address unique and critical national defense challenges and protect our nation's interests," said D-Wave Quantum CEO Dr. Alan Baratz in the press release. "By placing an Advantage quantum computing system onsite at Davidson's headquarters and creating a unique operating environment, we're opening up opportunities to tackle the US government's most pressing computational problems." In addition, D-Wave is reporting the results of a new study it commissioned with Hyperion Research, which revealed that a majority of surveyed businesses that are currently actively using quantum computing anticipate an "exceptional return on investment" (ROI) from their quantum optimization efforts. Specifically, the study reports an expected combined potential positive financial impact from quantum optimization investments, totaling up to an estimated $51.5 billion return for the surveyed organizations. The results, which were announced at D-Wave's global Qubits 2024 user conference, polled more than 300 organizations in the United States and the European Union.

"In my view, the data is clear: quantum computing has arrived as a critical business imperative," said Dr. Baratz in the press release. "Those who proactively embrace this technology and invest in optimization efforts stand to reap significant rewards. The anticipated gains and ROI projections paint a compelling picture of a possible near-term future where quantum computing becomes a fundamental driver of business success."

To view the full press releases, visit https://ibn.fm/SXKXf and https://ibn.fm/C1Xb4

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Friday's trading session at $1.16, up 1.7544%, on 6,087,233 volume. The average volume for the last 3 months is 889,422 and the stock's 52-week low/high is $0.57/$3.20.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene (NASDAQ: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis ("ALS") and multiple sclerosis ("MS"). Clene today announced that Karen Ho, Ph.D., the company's vice president of translational medicine, presented new, preliminary data demonstrating the potential of CNM-Au8(R) as a treatment for Rett Syndrome, a severe, rare pediatric neurologic disorder. Dr. Ho unveiled the data in oral and poster presentations on June 19 at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado. According to the announcement, CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome. Additionally, CNM-Au8 demonstrated rescue of mitochondrial deficits in induced astrocytes derived from Rett patients. "These preliminary data suggest that CNM-Au8 may treat Rett Syndrome by potential rescue of mitochondrial dysfunction, thereby promoting neuronal health, survival, and synaptic structure. If CNM-Au8 proves to be a successful treatment for Rett syndrome, this will add further affirmation to Clene's central thesis: that CNM-Au8 – with its versatile and unique catalytic mechanism – holds promise as a potential treatment for multiple diseases of the nervous system, beyond its current targets of ALS and MS. It's a truly rewarding time to participate in the development of CNM-Au8, which has strong potential to make a difference to the millions of people living with difficult-to-treat neurologic diseases," said Dr. Ho.Clene (NASDAQ: CLNN) (along with its subsidiaries, "Clene") and its wholly owned subsidiary Clene Nanomedicine Inc., is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis ("ALS") and multiple sclerosis ("MS"). Clene today announced that Karen Ho, Ph.D., the company's vice president of translational medicine, presented new, preliminary data demonstrating the potential of CNM-Au8(R) as a treatment for Rett Syndrome, a severe, rare pediatric neurologic disorder. Dr. Ho unveiled the data in oral and poster presentations on June 19 at the International Rett Syndrome Foundation 2024 Annual Meeting in Westminster, Colorado. According to the announcement, CNM-Au8 demonstrated neuroprotective effects in an in vitro model of Rett Syndrome. Additionally, CNM-Au8 demonstrated rescue of mitochondrial deficits in induced astrocytes derived from Rett patients. "These preliminary data suggest that CNM-Au8 may treat Rett Syndrome by potential rescue of mitochondrial dysfunction, thereby promoting neuronal health, survival, and synaptic structure. If CNM-Au8 proves to be a successful treatment for Rett syndrome, this will add further affirmation to Clene's central thesis: that CNM-Au8 – with its versatile and unique catalytic mechanism – holds promise as a potential treatment for multiple diseases of the nervous system, beyond its current targets of ALS and MS. It's a truly rewarding time to participate in the development of CNM-Au8, which has strong potential to make a difference to the millions of people living with difficult-to-treat neurologic diseases," said Dr. Ho.

To view the full press release, visit https://ibn.fm/ZGbxh

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Friday's trading session at $0.3963, up 1.3037%, on 1,399,037 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $3.20/$.

Recent News

Freight Technologies Inc. (NASDAQ: FRGT)

The QualityStocks Daily Newsletter would like to spotlight Freight Technologies Inc. (NASDAQ: FRGT).

Freight Technologies (NASDAQ: FRGT) ("Fr8Tech"),  an innovative logistics technology solutions company offering its custom-developed Fr8App, an industry-leading freight-matching platform powered by AI and machine learning that offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region, is announcing the expansion of its relationship with Amazon Mexico. According to the announcement, the expanded relationship now includes U.S.-Mexico cross-border shipping, with Fr8App now providing dual logistics services for Amazon Mexico. This expansion follows the December 2023 announcement that Fr8App had been selected for the second consecutive year to help manage the logistics needs of Amazon's high-demand season within Mexico. "We are honored to further strengthen our business relationship with Amazon Mexico and to broaden our scope of service. This expansion squarely fits within Fr8Tech's long-term vision of becoming a leading logistics partner in North America and speaks volumes about the confidence being placed in Fr8App's capabilities and our commitment to delivering solutions to corporations of all sizes," Javier Selgas, Fr8Tech's CEO, said.

To view the full press release, visit https://ibn.fm/eqPxc

Freight Technologies Inc. (NASDAQ: FRGT) (“Fr8Tech”) is a technology company developing solutions to optimize and automate the supply chain process, providing a platform for B2B cross-border shipping in the NAFTA region. The company’s mission is to revolutionize cross-border shipping by providing carriers with increased growth opportunities and shippers with flexibility, visibility and simplicity for the once-complex process of international over-the-road shipping.

Freight Technologies, formerly known as Hudson Capital Inc., assumed its current name and ticker symbol on May 27, 2022. Its primary operating subsidiary and its marketplace are known as Fr8App, and it conducts operations throughout North America under the names of Fr8App and/or Freight App. The company is headquartered in Houston, Texas, with multiple locations across the U.S. and Mexico.

The Fr8Tech Solutions Suite

Fr8Tech leverages artificial intelligence to provide cloud-based platforms aimed at automating the over-the-road transportation process, effectively reducing human touch points and expediting load booking times. The company’s suite of solutions includes:

  • Fr8app – A B2B marketplace powered by AI and Machine Learning offering a real-time broker portal to connect shippers with qualified carriers
  • Fr8Radar – A tracking solution providing shippers and carriers real-time locational data via Fr8app’s mobile solution or through integration with third-party GPS alternatives
  • Fr8TMS – A transportation management system designed to help shippers manage their freight and all of the documents involved in shipping transactions, including invoices, customs documents, confirmation rates and proof of deliveries
  • Fr8FMS – A fleet management system allowing transportation companies to better manage their fleets, reduce operational costs and provide better service to their customers
  • Fr8Data – A data solution offering real-time dashboards and reports to shippers and carriers in an effort to increase visibility and control while supporting better business decisions
  • Fr8Fleet – A platform that provides private fleet management, enabling large corporate shippers to purchase dedicated capacity secured by Fr8app in exchange for a fixed fee

Commitment to the Environment

Through its core focus on technology, Fr8Tech seeks to reduce the carbon footprint of the logistics industry. Its solutions aim to minimize empty miles for transportation firms and reduce overall paper consumption.

Fr8University

Fr8University is an educational program offering classroom and on-the-job training for Fr8Tech team members. Through the program, employees learn in-depth business fundamentals and applications along the truckload freight industry value chain.

Led by corporate educator Mario Mena, Fr8University is designed as an investment in the company’s human capital, providing an opportunity to communicate Fr8Tech’s corporate culture while accelerating operational growth.

Market Outlook

Fr8Tech’s established foothold in Mexico is key to its current efforts to promote sustainable growth in the cross-border shipping industry. Ongoing disruption in U.S.-Chinese trade relations have strengthened Mexico’s status as the largest trading partner of the U.S., with cross-border annual freight spending estimated at $385 billion according to data from the U.S. Department of Transportation. Annual domestic shipping in Mexico is estimated at $34 billion, while annual domestic shipping in the U.S. is estimated to total $732 billion.

Despite the size of this industry, fragmentation and inefficiencies prevail in the space. Thousands of legacy brokers, tens of thousands of shippers and hundreds of thousands of carriers still rely on outdated systems to arrange transport, spending hours on the phone negotiating pricing, waiting days to find trucks and drivers, preparing and printing forms, and operating without tracking or visibility. Add in cross-border complexity relating to customs and additional paperwork, and you have an industry ripe for technological disruption.

Fr8Tech’s recent revenue growth trends have highlighted the company’s efforts to capitalize on this opportunity. In 2021, Fr8Tech achieved revenues of $21.5 million, marking a year-over-year increase of 134%. The company issued revenue guidance for fiscal 2022 of $40 million in a February 9, 2022, press release, which would account for a further 86% year-over-year increase.

Management Team

Javier Selgas is CEO and a Director of Freight Technologies Inc. and Freight App Inc. He brings to the company over 15 years of experience developing technology and digital marketing strategies, including serving as Country Manager for Osigu, Spain, and as head of AJEgroup’s IT division for the Asia-Pacific region. Prior to joining Fr8Tech, Mr. Selgas founded digital marketing agency Lanzadera Online. He has also served as an IT consultant to major corporations, including Endesa and Ibermatica.

Mike Flinker is President of Fr8Tech. He has over four decades of experience in the transportation industry, with 30+ years focused on cross-border logistics. Prior to joining Fr8Tech, Mr. Flinker founded FLS Transportation, the largest cross-border logistics company in Canada. He also previously held positions with Clarke Transport Inc., Canadian Pacific and Reimer Express Inc. (a division of Roadway Express).

Paul Freudenthaler is the company’s CFO and Secretary to the company Board. He has over 30 years of financial expertise, having previously served as CFO for several leading companies across multiple countries, including Macquarie in Mexico, Old Mutual in Latin America and Ascentium Capital in the U.S. Mr. Freudenthaler’s experience include leadership roles from which he guided IPOs and M&A transactions.

Luisa Lopez is COO of Fr8Tech. She brings to the company 25+ years of management experience in logistics, supply chain, operations and customer service. Ms. Lopez previously served as a Director of Landstar, where she was responsible for commercial and client development strategies in the Mexican market. Additionally, she managed more than 2,000 transport units specialized in staff and school mobility while with Traxion in Mexico.

Freight Technologies Inc. (NASDAQ: FRGT), closed Friday's trading session at $0.3696, up 0.6810133%, on 3,429,047 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3303/$14.00.

Recent News

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF)

The QualityStocks Daily Newsletter would like to spotlightFathom Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF).

The company has released a fact sheet outlining progress on its high-grade copper and gold deposits in the state of Virginia and in Nunavut, Canada

U.S Global Investors reports that gold and copper are "pivotal players" in the global financial market

With rising demand as the backdrop, the progress that Aston Bay is reporting at its Canadian and U.S. projects is particularly promising

With gold and copper trending upward, Aston Bay Holdings (TSX.V: BAY) (OTCQB: ATBHF), a publicly traded mineral exploration company, is strengthening its position in both sectors. The company recently released a fact sheet (https://ibn.fm/IKzqR), titled "Discovering High-Grade Copper and Gold in North America," outlining progress on its high-grade copper and gold deposits in the state of Virginia and in Nunavut, Canada.

Aston Bay Holdings Ltd. (TSX.V: BAY) (OTCQB: ATBHF) is a publicly traded Canadian minerals exploration company focused on exploring high-grade copper and gold deposits in North America. The company owns the Storm Copper Project and the Seal Zinc Deposit in Nunavut, Canada, and is currently exploring the Buckingham Gold Vein and critical metals prospects in central Virginia. Aston Bay is also in the advanced stages of negotiation on other properties with high-grade critical minerals potential in these areas.

The company believes in responsible exploration and carries out its work programs to the highest standards of social responsibility, environmental stewardship and health and safety. Aston Bay cares about leaving a net positive impact on the communities in which it works and engages with local representatives, Indigenous groups and government agencies to build respectful relationships through dialogue and collaborative processes. Depending on the stage of exploration, these efforts may include employment, contracting, training, community benefits and other agreements.

Aston Bay conducts exploration through safe, socially and environmentally responsible and sustainable work practices. The company embeds core values of health and safety throughout its operations by adhering to strict health and safety standards and practices that meet and/or exceed industry standards and government codes and regulations.

The company is headquartered in Toronto.

Projects

Storm Copper

The high-grade Storm Copper Deposit is located 112 kilometers south of the community of Resolute Bay, Nunavut, on western Somerset Island, just south of the past-producing Polaris Pb-Zn Mine. The property comprises 173 contiguous mining claims, including the Storm Copper and Seal Zinc projects, covering an area of approximately 541,795 acres.

The property has good access to established shipping lanes, and the landscape provides favorable conditions for development of roads and a protected deep-water port. Exploration is supported through excellent infrastructure in the nearby hamlet of Resolute Bay.

Aston Bay is partnered with American West Metals (ASX: AW1) at Storm. American West is responsible for all exploration expenditures, having aggressively advanced the project toward production and earned an 80% interest. This affords excellent optionality to the company’s shareholders, as Aston Bay is free carried with no required expenditures until the completion of a bankable feasibility study.

American West recently completed an Australian JORC-compliant Maiden Resource Estimate for Storm; the North American 43-101 compliant resource estimate is expected in Q1 2024. American West is cashed up and plans a multimillion-dollar resource expansion and new discovery drilling program for the summer of 2024.

The Buckingham County Gold Project

The gold-bearing system at the Buckingham County Gold Project in Virginia lies within a belt hosting past producing mines, current gold mines and advanced gold explorations, stretching through Georgia, the Carolinas, Virginia, Nova Scotia and Newfoundland.

Buckingham hosts a “Kirkland Lake-style” high grade gold vein returning values consistently over one ounce gold per ton and is underexplored both at depth and along almost one mile of strike length. These types of veins have excellent ESG qualities, as they are typically mined using a small footprint underground method, with gold extracted using simple and environmentally friendly gravity methods.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

A report from Acumen Research and Consulting, a global provider of market intelligence and consulting services, valued the global copper market at $304.1 billion in 2022 and forecast that it will reach a market size of $496.8 billion by 2032, growing at a CAGR of 5.1% over the forecast period.

The report identifies a growing demand for copper in the electronics industry, as well as an expanding copper supply due to increasing production from existing mines and the rising number of mine development projects in developing nations, as driving factors in the rising value of the copper market.

Management Team

Thomas Ullrich is CEO and Director of Aston Bay. He has over 30 years of experience in mineral exploration and geoscience. Before joining Aston Bay, he was Chief Geologist North America for Antofagasta Minerals plc, investigating copper potential through extensive property evaluations and management of drill programs in the United States, Mexico and Canada. Prior to that, he was Senior Geologist for Almaden Minerals.

Sofia Harquail handles Investor Relations and Corporate Development at Aston Bay. She has over 15 years of experience in the private and public sectors of the mining industry. Before joining Aston Bay, she worked as a consultant for the Prospectors and Developers Association of Canada and for exempt market dealer Red Cloud Financial Services Inc. Ms. Harquail holds an M.A. from the University of Uppsala in Sweden and received her CPIR designation from the CIRI/Ivey Investor Relations Program. She also sits on the board of the Young Mining Professionals Toronto and is CSC Certified.

Aston Bay has a talented Board of Directors bringing broad experience from across the industry, encompassing resource expansion, mine development, mergers and acquisitions, and mining finance.

Ms. Jessie Liu-Ernsting has over 15 years of experience in the mining industry, spanning capital projects engineering, debt capital markets, private equity and corporate strategy at several firms, including Hudbay Minerals and Resource Capital Funds. She is currently VP Investor Relations and Communications at G Mining Ventures Corp.

Mr. Jeffrey R. Wilson has over 25 years’ experience in the mining industry, having served as a director, officer and advisor of multiple public and private companies in the mineral exploration and mining investment industries. Mr. Wilson is currently President & CEO of Precipitate Gold Corp.

Mr. Gary O’Connor has over 40 years of diverse experience as a mineral exploration and development professional in the management of successful resource projects as well as the evaluation, technical due diligence, and supervision of large mineral exploration and development projects through-out the world. While with Freeport, Mr. O’Connor worked on the due diligence and discovery of a major gold fraud on the Busang gold “deposit” in Kalimantan by Bre-X.

Mr. Mark J. Pryor is a geologist with a 40-year track record of successfully advancing multiple precious metal, copper, coal, REE and Li projects from discovery through to exploitation. He is currently Executive Vice President of the Exploration Division at The Electrum Group.

Aston Bay Holdings Ltd. (OTCQB: ATBHF), closed Friday's trading session at $0.1031, up 33.7224%, on 600,990 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0268/$0.2474.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Earlier this week, the European Council announced that it had made its decision on proposals focused on protecting consumers from greenwashing. In its agreement, the council set the requirements for companies to prove and verify labels and claims on the environmental attributes of their services and products. The decision also reflects the council's position on the Green Claims Directive, which was introduced by the European Commission last year. The directive's aim was to address the need for verifiable and reliable information for consumers. From the above, we can see that the position of the council affords companies more flexibility in comparison to the proposals made by the commission, which would require any green claim to be substantiated by third-party independent experts. Under the council, the need to verify ecolabeling schemes would also be exempt in the European Union, as long as companies complied with the new rules. For entities that focus on the production of metals to facilitate the shift to more sustainable economies, such as Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF), the likelihood of greenwashing their products is minimal.

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Friday's trading session at $0.04081, up 0.2210216%, on 6,100 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0306/$0.35.

Recent News

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF)

The QualityStocks Daily Newsletter would like to spotlightFathom Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) .

Ontario, Canada-based Tartisan Nickel Corp. is developing a number of mining exploration projects that will provide resources for the electric vehicle and hybrid automobile battery market

Tartisan recently announced the acquisition of additional land to increase the size of its flagship project in Ontario's Kenora Mining Division to 4,273 hectares (more than 10,500 acres)

Tartisan owns two other exploration projects in Ontario and one in central Peru

The company is dedicated to responsible social and environmental stewardship as nickel mining's chain of custody comes under a growing degree of public and investor scrutiny

In spite of the challenges that naturally accompany any foundational shift in a major industry, such as the introduction of EV technology to world transportation, it's clear that the still developing EV industry is here to stay. Problems will be addressed, infrastructure will be created, and the material and technological demands of the sector will continue to grow. Canadian mineral and battery metals explorer Tartisan Nickel (CSE: TN) (OTCQB: TTSRF) is confident of this long-term growth. Market forecasts anticipate EV sales jumping from 18 percent of global passenger vehicle sales last year to 45 percent by the end of the decade, and 73 percent by 2040, according to the Los Angeles Times (https://ibn.fm/yROn1).

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) is a Canadian mineral and battery metals exploration and mining development company. Tartisan’s flagship asset is the Kenbridge Nickel Project. Located in the Kenora Mining District, in the Province of Ontario, the Kenbridge Nickel Project is an advanced staged nickel deposit with a measured, indicated and inferred resource and has an existing 622-meter three compartment shaft.

As the world looks to utilize electric vehicles (EVs) in an effort to reduce air pollution, demand for EV battery metals is on the rise. Nickel is one of these in-demand battery metals, and there are few new, high grade development projects ready to meet this opportunity. Silver, zinc, copper and even lead are also part of this transformation in the EV sector. Tartisan Nickel Corp. is an advanced stage mining development company in a mining friendly jurisdiction. The company is headquartered in Toronto, Ontario, Canada.

Projects

The company’s flagship Kenbridge Nickel Project is in the north-central part of the Atikwa Lake area and the south-central part of the Fisher Lake Area in the Kenora Mining District, approximately 70 kilometers east-southeast of the Town of Kenora in northwestern Ontario. The property is accessible via gravel roads from paved Highway 71. The Kenbridge Nickel Project is covered by patented and unpatented mining claims totaling 10,150 acres.

Tartisan’s project portfolio also includes:

  • The Don Pancho Manganese Silver Zinc Project is in a prolific polymetallic mineral belt in central Peru with several operating mines in the area, including the world-class Iscaycruz and Yauliyacu polymetallic mines, operated by Glencore Xstrata PLC, which are located 50 kilometers to the north-northwest. Additionally, Travail Mining Corporation’s Santander silver-lead-zinc mine is located just nine kilometers to the east and Buenaventura’s silver-lead-zinc Uchucchacua mine, which produced 10 million ounces of silver in 2011, is located 63 kilometers to the north.
  • The Turtle Pond Nickel Copper Project includes 105 staked units covering approximately 5,440 acres in northwestern Ontario, approximately 40 kilometers south of the town of Dryden in the Turtle Pond and Ukik Lake area. The claims are located approximately 70 kilometers east of the company’s flagship Kenbridge Nickel Project.
  • The Sill Lake Lead Silver Project is located approximately 30 kilometers north-northeast of Sault Ste. Marie in Vankoughnet Township in the Sault Ste. Marie Mining District of Ontario. The Sill Lake Property comprises 57 contiguous mining claims totaling approximately 2,850 acres.

Market Opportunity

A report by Grand View Research, a market research and consulting company, estimated the global nickel mining market to be worth $50.4 billion in 2022 and projected the market will grow to a value of more than $84.04 billion by 2030, achieving a CAGR of 6.6% over the forecast period.

Nickel alloy is a component of EV, portable electronics and power tool batteries. In addition, nickel is one of the key raw materials of stainless steel. Hence, development in the EV industry and growth in stainless steel end-use industries such as construction, consumer durables and machinery and equipment contribute to the growth of the market.

According to the Nickel Institute, the industry association for the world’s nickel producers, over two-thirds of the world’s nickel is currently utilized in the production of stainless steel.

Management Team

D. Mark Appleby is President, CEO and Director of Tartisan Nickel. He has more than 37 years of experience in a variety of disciplines relating to investment banking, corporate finance and capital markets. His career began at Manulife in the equity and fixed income departments. He later joined First Boston Canada, where he reached the position of Vice President, Bond Trading. Subsequently, he has worked as an investment executive with Scotia Mcleod Inc. and is co-founder of The Atlantis Group. He also served as a Director of Guyana Goldfields Inc. for five years.

Omar Gonzalez is CFO of Tartisan Nickel. He has over 20 years of experience in audit and assurance in South America, as well as five years of public and private audit practice, financial analysis and corporate development in Canada. He has led many assurance and non-assurance engagements for companies in the energy, mining and natural resources, real estate, manufacturing and consumer business sectors. He is a Chartered Professional Accountant in Venezuela and holds a bachelor’s degree in accounting from the Universidad Santa María in Caracas.

Tartisan Nickel Corp. (OTCQB: TTSRF), closed Friday's trading session at $0.13, even for the day, on 5,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.04685/$0.1905.

Recent News

Bebuzee Inc. (OTC: BBUZ)

The QualityStocks Daily Newsletter would like to spotlightFathom Bebuzee Inc. (OTC: BBUZ) .

Bebuzee is a leading social media and digital entertainment platform dedicated to providing innovative and engaging experiences for its users

The company recently launched its "super app", set to redefine the digital landscape by combining multiple services into a single intuitive platform

As part of Bebuzee's commitment of catering to the ever-evolving needs of modern social media users, the company has now launched two groundbreaking live streaming features in its super app

The features include a TikTok-style live streaming offering that allows users to broadcast short, engaging live videos to their followers in real time, and a YouTube-style live streaming feature that supports longer live broadcasts

The rollout of live streaming features marks a significant milestone in Bebuzee's journey to transform the digital entertainment landscape

The Digital 2024: Global Overview Report, published by DataReportal in partnership with We Are Social and Meltwater, revealed that 22.7% of social media users aged 16 to 64 cite watching live streams as their main reason for using social media platforms (https://ibn.fm/OvEUD). This was a marginal decrease from the 23.7% recorded in the Digital 2023: Global Overview Report (https://ibn.fm/I4aVA). Interestingly, for the second year running, watching live streams outranked reasons such as making new contacts, seeing content from users' favorite brands, watching or following sports, networking or research, following celebrities or influencers, and posting life updates. This relatively high interest in live streaming among social media users has not gone unnoticed, with social media companies introducing live streaming features to keep users on their platforms longer and satisfy the needs of users who love watching live streams. One such company is Bebuzee (OTC: BBUZ), a leading social media and digital entertainment platform dedicated to providing innovative and engaging experiences for its users. Bebuzee recently launched two groundbreaking live streaming features in its revolutionary super app: a live streaming feature that supports short live broadcasts and another that supports longer, more in-depth live broadcasts (https://ibn.fm/kLR9L).

Bebuzee Inc. (OTC: BBUZ), formerly Engage Mobility Inc., is a social platform and streaming service focused on development and deployment of America’s first superapp. The superapp will allow members to watch a wide variety of content, such as movies, series, documentaries and talk shows, on any internet-connected device.

Bebuzee’s technology scans the world’s news, features and information-flow to give its dedicated readers the best of the internet in one place – a one-stop platform for breaking news, interesting and important blogs, videos and photos.

The core features of the superapp include video streaming; photo sharing; Bebuzee Messaging service, which allows users to send text and voice messages and make voice and video calls; Shortbuz, used to make a variety of short-form entertaining videos; Blogbuz, a resource for people without time to scavenge the internet and other sources for news and information; Properbuz global real estate search; global tradesmen search; location reviews of neighborhoods, cities and even regions to help others find their ideal rental or real estate purchase; ShoppingBuz, a unique technology-driven e-commerce platform which gives merchants incredible tools to sell their products; Bebuzee Pay, a mobile payment and digital wallet service that allows users to make mobile payments and online transactions; TravelBuz, an online travel booking service; EventBuz, a ticket exchange and resale platform; and FlightBuz, a flight search engine.

The company is headquartered in Miami.

Introducing the Superapp to Western Markets

A superapp is a mobile phone app that offers a wide range of services within a single platform. This technology allows users to access various services without downloading and switching between multiple apps.

While superapps are popular in many parts of the world, including Latin America, Africa, the Middle East, Asia and Russia, they have achieved little adoption in Western markets. Perhaps the most widely known superapp is WeChat, which is estimated to have as many as 1.24 billion users, mostly in China.

Bebuzee aims to be the first developer to introduce and grow to widespread popularity a superapp in the U.S. and Europe. It took a strong step toward achieving this goal during the COVID-19 pandemic, when Bebuzee’s user base surged by 78% with over 42 million new users.

Whereas most social platforms are generic and only local postings make them somewhat relevant to local communities, Bebuzee has localized its platform for most countries by providing local content, entertainment and information that is frequently updated and refreshed.

The company says the average age of its superapp users is 39, with female users making up 62.8% of its user base. Its monetization strategy includes sales of video advertising, sponsored posts, banner ads and premium listings, as well as promotion of featured brands and property listings.

Market Opportunity

A report from Allied Market Research, a global market research, consulting and advisory firm, estimated that the worldwide superapps market was valued at $58.6 billion in 2022. The report projects the market to expand to $722.4 billion by 2032, growing at a CAGR of 28.9% for the forecast period.

The report identifies a few of the most popular superapps as Rappi in Latin America, Snapp in Iran, Line in Japan and Yandex Go in Russia and Kazakhstan.

Increasing adoption of mobile services and growing advancements in digital technologies are driving the growth of this market. In addition, a rise in government support for promoting the use of superapps is lending to expansion, according to the report.

Integration of blockchain technology in superapps is likewise anticipated to provide numerous opportunities for the expansion of the market during the forecast period, the report states.

Management Team

Joseph Onyero is Founder and CEO of Bebuzee. He has a background of managing multiple products from ideation to market launch and profitable monetization and has been building commercial web presences since 2005. He has worked as a Chief Marketing Officer and in business development. He previously owned and operated a travel and tourism company. He began in 2005 working on the concept and features that have evolved into the Bebuzee suite. He has grown Bebuzee from a living room start-up into a U.S. publicly traded company.

Claudia S. Spagnuolo is Chief Operating Officer at Bebuzee. She began with the company in 2014 as a user experience manager before being promoted to CMO in 2017. She previously worked as an assistant marketing director at the National Secretariat of the union CISL in Italy. Prior to that, she also worked as a researcher at the Complutense University of Madrid on issues of corporate management. She speaks three languages and holds a bachelor’s in political science and a master’s in administration from the University of Perugia in Italy.

Bebuzee Inc. (OTC: BBUZ), closed Friday's trading session at $0.047, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.01955/$0.359.

Recent News

Software Effective Solutions Corp. (OTC: SFWJ)

The QualityStocks Daily Newsletter would like to spotlight Software Effective Solutions Corp. (OTC: SFWJ).

The Biden administration has expressed its opposition to a proposal that would prevent military branches from testing for cannabis use as part of the commissioning or enlistment process, noting concerns about how it could impact military readiness and safety. The White House Office of Management and Budget (OMB) released a statement on June 11, 2024, outlining its policy concerns regarding various elements of the 2025 NDAA. The bill is currently under consideration by the Rules Committee for upcoming House action. One specific provision that the administration opposes is Section 532. This section would prohibit military branches from requiring cannabis tests for individuals as a condition of their enlistment or commissioning as officers in the Armed Forces. The OMB highlighted that while it has an appreciation for Congress's intent to expand the pool of potential military recruits, the office opposes Section 532 because it would stop the U.S. Department of Defense (DoD) from testing applicants for delta-8 and delta-9 THC, the active components in cannabis. Biden has been praised for his other marijuana-related initiatives, even despite these points of dispute. Notably, the U.S. Department of Justice (DOJ) recommended reclassifying marijuana as a result of his directive to reassess the drug's federal classification. He has also granted two rounds of mass cannabis pardons. This position of the White House is unlikely to be surprising to marijuana companies such as Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) given that such a policy change for the military can only happen once significant reforms have been enacted at the federal level.

Software Effective Solutions Corp. (d/b/a MedCana) (OTC: SFWJ) is a global infrastructure and holding company in the cannabis industry. MedCana currently has five companies focused on pharmaceutical cannabis production, as well a software company focused on managing processes for plant-to-patient operations. The recent acquisition of an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of holdings.

MedCana’s focus is on developing clients and companies in Latin America, initially in Colombia, and partnerships with laboratories, research facilities and hospitals throughout the world. MedCana is building the technology, laboratories, growing facilities and scientific teams to provide premium pharmaceutical-grade cannabis extracts to the world.

MedCana’s goal is to be the world’s premier resource for pharmaceutical cannabis products. The company believes its advantage is its global view and reach. From initial cultivation to final product, MedCana aims to help partners produce pharmaceutical CBD and other extracts that will have no equal.

The company’s mission is to utilize its technology to partner with and develop companies that provide premium pharmaceutical-grade cannabis extracts with absolute integrity, sustainability and social responsibility. MedCana’s team of pharmaceutical scientists includes some of the most respected chemists in the world. They aim to ensure that the company’s customers and partners create premium cannabis extracts that meet the growing worldwide demand. MedCana’s software is designed to ensure traceability and quality from seed to finished product.

MedCana is headquartered in Austin, Texas, with offices in Colombia.

Production

MedCana announced in May 2023 the beginning of full-scale production of non-THC cannabis for export to Europe in response to high demand in that market. This expansion comes after the successful completion of full crop cycle testing and infrastructure development at production sites in Columbia.

The recent acquisition of the assets of Tokan Corp., a software company focused on creating an enterprise resource planning (ERP) platform for the cannabis industry, and Eko2O S.A.S., a greenhouse and irrigation engineering company, has positioned MedCana for explosive growth in the region.

As a MedCana subsidiary, Eko2O SA will increase the company’s revenue potential in Central and South America. The subsidiary specializes in the construction and distribution of greenhouses and sophisticated irrigation platforms. A positive outlook has resulted from the company’s expansion as it investigates new opportunities for greenhouse and irrigation system installations in Panama and Uruguay. These opportunities are expected to accelerate Eko2O’s development and strengthen its position as a top supplier of innovative agricultural solutions in cannabis and other sectors that are quickly moving to high technology agricultural production.

In addition, MedCana has started talks with the government in Argentina about possible incentives for beginning operations in that country as part of its ongoing worldwide development strategy. Support from the Argentinean government and the start of new operations there would greatly increase MedCana’s market share in Latin America and solidify the company’s position as the market leader in the cannabis industry.

Market Opportunity

According to a report by Grand View Research, a San Francisco-based market research and consulting company, the global cannabis extract market was valued at $3.5 billion in 2022 and is expected to expand at a CAGR of 20% from 2023 to 2030 to be worth more than $15 billion.

Growing demand for cannabis extracts, including oils and tinctures, and the increased legalization of marijuana for the treatment of different chronic ailments like arthritis, Alzheimer’s, anxiety and cancer are driving the expansion of the industry. The marijuana derivative industry is flourishing due to a greater understanding of its various medical benefits.

Management Team

Jose Gabriel Diaz is CEO of MedCana. He has successfully built, grown and sold multiple telecom companies. He was senior vice president of sales at IP Communications, a national high-speed data provider. He also founded Reallinx, a national data carrier later sold to GTT Communications. Additionally, he is currently president of the A.E.M. Business and Entrepreneurship Association in Austin, Texas.

Claudio Jiménez Cartagena, QF, Ph.D. is Chief Scientific Officer at MedCana. He joined MedCana after working with Sosteli Pharma as Technical Director and serving as a director consultant for the Corporation for Agricultural Industrial Development at the University of Antioquia in Colombia. Before that, he worked as the scientific director at the Institute of Food Science & Technology. He holds a bachelor’s degree in pharmaceutical chemistry, a master’s degree in basic biomedical sciences and a doctoral degree in Environmental Engineering from the University of Antioquia.

Julián Alberto Londoño Londoño, Ph.D., is Senior Vice President of Operations at MedCana. He previously served as general manager for the Corporation for Agricultural Industrial Development, and as Chief Scientific Officer at Sosteli Pharma in the Resource Management Department. He has developed multiple U.S. patents, and recently served as senior advisor to the Secretariat of Agriculture Development for the Government of Antioquia. He holds a doctorate in Chemical Sciences from the University of Antioquia.

Software Effective Solutions Corp. (OTC: SFWJ), closed Friday's trading session at $0.0275, even for the day, on 2,000 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.000001/$0.09.

Recent News

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX)

The QualityStocks Daily Newsletter would like to spotlight McEwen Mining Inc. (NYSE: MUX) (TSX: MUX).

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on the progress at the Fox Complex, where McEwen is advancing a new mine on the Stock Property. According to the announcement, production is expected to start later this year, with preconstruction activities of the stock portal already begun. The company noted that current activities will allow access to mining of the West, Main and East gold zones. "In addition, the portal will provide cost-effective underground drill platforms to enable testing for expected depth extensions of these three zones," said the company in the press release. "Recent exploration resulted in a 29% increase in the estimated gold resources for Stock's East Zone. The Fox Complex is comprised of several properties, including Stock, and has Measured and Indicated gold resources of 1,905,000 ounces at average grade of 4.20 g/t Au and Inferred gold resources of 549,000 gold ounces at average grade of 3.60 g/t Au."McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on the progress at the Fox Complex, where McEwen is advancing a new mine on the Stock Property. According to the announcement, production is expected to start later this year, with preconstruction activities of the stock portal already begun. The company noted that current activities will allow access to mining of the West, Main and East gold zones. "In addition, the portal will provide cost-effective underground drill platforms to enable testing for expected depth extensions of these three zones," said the company in the press release. "Recent exploration resulted in a 29% increase in the estimated gold resources for Stock's East Zone. The Fox Complex is comprised of several properties, including Stock, and has Measured and Indicated gold resources of 1,905,000 ounces at average grade of 4.20 g/t Au and Inferred gold resources of 549,000 gold ounces at average grade of 3.60 g/t Au."

To view the full press release, visit https://ibn.fm/YvbzG

McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) is an asset rich diversified gold and silver producer in the Americas with a large exposure to copper through its subsidiary, McEwen Copper, owner of the Los Azules copper deposit in Argentina, believed to be the 8th largest undeveloped copper resource in the world.

Led by a management team with a track record of success, MUX owns and operates mines in some of the most prolific gold producing regions of the Americas. The company proactively took cost-saving measures months ago to lower expenses and increase production across its portfolio of gold assets, driving some production costs below industry averages. Gold and copper prices, already in an upswing, are forecast to enter an explosive uptrend over the next couple years. Drawing from its experience, McEwen Mining planned, prepared and laid the groundwork to capitalize on this emerging opportunity.

The company currently holds a Zacks Rank #1 (Strong Buy), placing it in the top 5% of over 4,000 stocks ranked by Zacks, based on trends in earnings estimate revisions and EPS surprises. Seldom is management so aligned with investors’ interests and committed to the company’s success. With a combined investment of over $220 million, CEO Rob McEwen holds a 17% ownership stake in McEwen Mining and a 13% ownership in McEwen Copper. Acclaimed in the mining industry, McEwen founded Goldcorp, where he increased the company’s market capitalization 160 times – from $50 million to over $8 billion. That same vision and tenacity led MUX in creating McEwen Copper.

For McEwen Mining shareholders, beyond the company’s exposure to gold upsurges, its 47.7% stake in McEwen Copper is expected to be a blockbuster, turbocharging MUX by creating the world’s next prolific copper unicorn.

McEwen Copper

With continuous industrial need, new critical demand for copper is rapidly emerging, increasingly driven by the green energy transition. The price of copper rose from a low of about $2 per pound in 2020 to over $4.60 per pound in May 2024, and strong demand is expected to intensify. A study by S&P Global, titled The Future of Copper: Will the Looming Supply Gap Short-circuit the Energy Transition?, projects global copper demand to nearly double over the next decade, from 25 million metric tons today to about 50 million metric tons by 2035. Based on current trends, S&P Global forecasts annual supply shortfalls to reach nearly 10 million metric tons in 2035.

McEwen Mining owns a 47.7% equity stake in McEwen Copper, the holder of a 100% interest in the Los Azules copper project in San Juan, Argentina, which is ranked the 8th largest undeveloped copper deposit in the world. Current copper resources at Los Azules are estimated at 10.9 billion pounds at a grade of 0.40% Cu (Indicated category) and an additional 26.7 billion pounds at a grade of 0.31% Cu (Inferred category). McEwen Copper also owns a copper exploration project in Nevada, USA, called Elder Creek.

In a 2023 Preliminary Economic Assessment (PEA), Los Azules was estimated to have a 27-year life, producing an average of 322 million lbs. of copper cathode annually, at a cash cost of $1.07 per lb. of copper, in the lowest quartile of the copper cost curve. The project could ultimately become an even larger mine with a longer life, since the extent of mineralization has not been fully assessed on the property.

The project’s 2023 PEA presents a distinctly different development strategy from a prior PEA published in 2017. By proposing a heap leach project using solvent extraction-electrowinning instead of the previously detailed mine with a conventional mill and flotation concentrator, McEwen Copper aims to decrease its environmental footprint and reduce permitting risk, albeit with a lower overall copper recovery, slightly higher unit costs and a delay in immediate cashflow due to extended leach cycles.

After securing a $25 million investment from mining giant Rio Tinto’s technology arm, Nuton LLC, McEwen Copper closed its non-brokered, private placement offering of $82 million in August 2022. Shortly after, in February 2023, Nuton agreed to invest an additional $30 million into McEwen Copper, and in October 2023, Nuton once again expanded its stake, investing an additional $10 million to bring its ownership position in McEwen Copper to 14.5%.

“We are extremely pleased to have Nuton’s strong continued participation in McEwen Copper,” Rob McEwen stated in a news release. “Together we are exploring new technologies that save energy, water, time and capital in the pursuit of delivering green copper to Argentina and the world, a product that will contribute to the electrification of transportation and the protection of our atmosphere.”

Also in February 2023, FCA Argentina S.A., a subsidiary of Stellantis N.V., one of the world’s leading automakers, invested ARS $30 billion in McEwen Copper. In October 2023, Stellantis invested an additional ARS $42 billion, bringing its current stake in McEwen Copper to 19.4%.

“We are delighted to have Stellantis as a partner in the future development of our Los Azules copper project,” Rob McEwen said of the investment. “Together, we share a vision to build a mine for the future based on regenerative principles that can achieve net-zero carbon emissions by 2038.”

Following the capital raise, McEwen Copper is well-funded to advance its Los Azules Project, with a Feasibility Study planned for Q1 2025. MUX strategically reduced its interest to increase its treasury, in order to reduce debt and fund the further development of its gold and silver assets.

Gold & Silver Projects

The Fox Complex

McEwen Mining owns a 100% stake in the Fox Complex in the heart of a prolific gold district in Timmins, Canada.

“When MUX bought the Fox Complex, in late 2017, it was a distressed asset with a history of high operating cost/oz. While it has taken longer than I expected, the cost to produce an ounce of gold is significantly lower,” CEO Rob McEwen stated in a news release.

McEwen Mining issued 2024 guidance for its cash cost/oz at the Fox Complex of $1,225-1,325 on annual production of 40,000-42,000 GEOs. Fox Complex produced 44,450 GEOs in 2023, which was within the company’s guidance range.

Located in one of the most prolific gold production areas in the world, along the Destor-Porcupine Fault Zone within the Abitibi Greenstone Belt, the Fox Complex includes the Black Fox mine and Froome mine which together have yielded over 1,000,000 ounces of gold to date. Also, the complex includes the Grey Fox and Stock deposits that have over 1,800,000 ounces in gold resources. The 2.7-billion-year-old Abitibi Greenstone Belt, formed by ancient volcanic activity, has proved to be one of the world’s richest and most abundant gold regions, with a total gold content currently estimated at over 300 million ounces.

In 2024, MUX commenced development of underground ramp access to the Stock orebodies at the Fox Complex. This development will become the primary source of feed following the completion of mining the Froome deposit in 2026. As part of the future mining sequence initiative, the company has already reported a 31% year-over-year increase of gold resources at Stock West and Stock Main (historical Stock Mine), with confirmation of good grading structures plunging to depth. It has also identified Stock East as a potential new near-term source of future revenue.

The Gold Bar Mine

McEwen Mining owns a 100% stake in the Gold Bar mine, located in an area well known for gold production, the southern Roberts Mountains of the Battle Mountain-Eureka-Cortez gold trend in Eureka County, Central Nevada. The Gold Bar mine is on the same geological structure, 25 miles south of Nevada Gold Mines, a Barrick-Newmont joint venture, part of the Cortez-Goldrush complex. This complex contains estimated reserves and resources of over 50 million gold ounces, with an annual production of 1,000,000 gold ounces.

Gold Bar had been mined between 1991 and 1994, producing 134,000 gold ounces. A new facility was built by MUX in 2019. Gold Bar accounted for 42,700 GEOs in 2023, within the company’s guidance for the year. For 2024, McEwen Mining issued guidance of 40,000-43,000 at a cash cost of $1,450-1,550. The first half of the year is expected to deliver higher production relative to the second half, due to a scheduled waste stripping phase in the Pick pit, in preparation for the 2025 mining program.

Notably, in April 2024, McEwen Mining announced its entry into a definitive agreement and plan of merger with Timberline Resources Corporation (TSX.V: TBR) (OTCQB: TLRS) in a transaction valued at roughly $18.8 million. The merger with Timberline is expected to augment McEwen’s existing portfolio of development and exploration projects in Nevada, leveraging synergies between Timberline’s projects and the Company’s Gold Bar mine.

El Gallo/Fenix

Project Fenix is the proposed redevelopment plan for McEwen Mining’s El Gallo Complex in Mexico. There is a long history of mining in this region. MUX began operating it as an open pit, heap leach mine in 2013, which produced 281,000 gold equivalent ounces at average cash cost of $655 per ounce. Due to the transition to deeper sulfide mineralization that is not amenable to heap leaching, mining activities ceased in the second quarter of 2018 and residual heap leaching followed until mid-2022. The redevelopment plan envisions constructing a mill at the existing mine site that will initially reprocess the existing heap leach material, then transition to open pit mining and processing of the sulphide mineralization. The company recently acquired a complete process plant on very advantageous terms that has considerably reduced the projected capital requirements for the project.

CEO Rob McEwen stated in a news release, “This acquisition has made Fenix more attractive to build and could provide a new long life mine for McEwen Mining.”

The initial development approach is to build a mill to reprocess the material on the heap leach pad and produce approximately 17,000 oz of gold annually for eight years. Construction of the Fenix project is expected to begin in the second half of 2024.

San José Mine

McEwen Mining is a 49% owner and non-operator of the San José gold and silver mine, located in Santa Cruz province, Argentina, encircling Newmont’s prolific Cerro Negro (approx. 300,000 gold ounces produced in 2023). This high-grade underground mine has been operating since 2007 and currently has an expected life of six years with a reserve grade of 296 gpt silver and 5.4 gpt gold.

Exploration is continuing to extend high-grade veins and discover new veins at the complex. San José’s drilling programs to define additional resources and reserves have a long history of success due to a high vein density, aided by good geophysical response from hidden veins.

Production guidance for 2024 for MUX’s 49% interest is 50,000-60,000 GEOs. As a minority shareholder in the mine, MUX equity accounts for its investment in San José, and receives 49% of the dividends from the mine’s free cash flow.

Market Outlook

Mining stocks suffered significant losses in the wake of the COVID-19 pandemic. However, this has turned, and many analysts now forecast a gold bull market in 2024 and beyond.

“The operating challenges we faced in recent years have severely damaged our credibility with our shareholders and the market. As a result, few investors have taken a close look recently at our assets,” Rob McEwen said in a news release. “If they did, I believe some would see the potential value that I see today… I believe there is considerable potential value in MUX, and that is a big reason why I have a personal financial commitment of $220 million in MUX and McEwen Copper.”

Management Team

Robert R. McEwen is Chairman, CEO and Chief Owner of McEwen Mining. He has been associated with the gold industry all his career, with his first 18 years in the investment industry and, since 1990, as CEO of several gold mining companies. He founded Goldcorp and took that company from a $50 million market capitalization to more than $8 billion. He owns 17% of McEwen Mining and is in complete alignment with investors – his investment in MUX and McEwen Copper is $220 million and he takes an annual salary of only $1. He was awarded the Order of Canada and the Queen Elizabeth’s Diamond Jubilee Award, was inducted into the Mining Hall of Fame, was named an Ernst and Young Entrepreneur of the Year and has Honorary Doctor of Law degrees from York University and Western University.

William Shaver is interim COO and a Director of McEwen Mining. He has decades of management and executive experience in mine design, construction and operations. He was a founder of Dynatec Corporation, which became one of the leading contracting and mine operating groups in North America. In 2013, he was recognized as Ernst and Young Entrepreneur of the Year. Most recently, he served as COO of INV Metals. He is a Professional Engineer with a B.Sc. in Mining Engineering from Queens University.

Perry Ing is interim CFO at McEwen Mining. He has 25 years of experience in the Canadian mining industry. Over the past 15 years, he has held positions as CFO of Mountain Province Diamonds, Kirkland Lake Gold and McEwen Mining. Prior to that, he worked at Barrick Gold and Goldcorp and started his career in the mining practice at PwC. He has a Bachelor of Commerce from the University of Toronto and is a Chartered Professional Accountant in Canada and Certified Professional Accountant in the U.S.

Adrian Blanco S. is the company’s Director of Operations for America and Mexico. He has extensive international experience in several industrial sectors and has held executive positions in Mexico, the United States, Peru and Argentina. He joined the McEwen Mining team in 2015 and has led a successful business transformation toward operational discipline, best business practices and financial profitability at subsidiaries Compañia Minera Pangea and McEwen Mining Nevada. He graduated from an Executive Management Program at IPADE and Harvard Business School.

Michael Meding is Vice President and General Manager of McEwen Copper. He has over 20 years of international experience, primarily with major mining companies such as Barrick Gold and Trafigura, including extensive experience with project development and operations in Argentina. While at Barrick Gold’s Veladero mine in Argentina, Mr. Meding played a key role in the turnaround, extension of the mine life and subsequent strategic partnering with Shandong Gold. He holds an MBA from Indiana University in Pennsylvania and an MBA from the Leipzig Graduate School of Management in Germany.

McEwen Mining Inc. (NYSE: MUX), closed Friday's trading session at $9.55, off by 0.7276507%, on 2,210,275 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $5.92/$12.50.

Recent News

Longeveron Inc. (NASDAQ: LGVN)

The QualityStocks Daily Newsletter would like to spotlight Longeveron Inc. (NASDAQ: LGVN) .

Longeveron (NASDAQ: LGVN) is a clinical stage regenerative medicine biotechnology company developing cellular therapies for rare, life-threatening and chronic aging-related conditions. Longeveron presented at the Virtual Life Sciences Investor Forum on June 20. The company's presentation is now available for online viewing 24/7 for 90 days.

To view the presentation, visit https://ibn.fm/RYzP8

To view the full press release, visit https://ibn.fm/VntPI

Longeveron Inc. (NASDAQ: LGVN) is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. The Company’s research and therapies are aimed at improving the outcome of infants born with a life-threatening heart condition, as well as improving the healthspan for the aging population – the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging, with function and ability to perform activities of daily living.

Longeveron is involved in clinical trials in the following indications: Hypoplastic left heart syndrome (HLHS), Alzheimer’s disease, and Aging-related Frailty.

The Company’s philosophy revolves around the idea that regenerative medicine may hold the potential to improve certain rare medical conditions and contribute to healthy aging. While there has been a remarkable rise in life expectancy over the last century due to medical and public health advancements, this increase in longevity has not been paralleled by the number of years a person is expected to live in relatively good health, free of chronic disease and disabilities of aging.

Longeveron’s lead investigational product is Lomecel-B™, an allogeneic Medicinal Signaling Cell therapy product isolated from the bone marrow of young, healthy adult donors. As humans age, they experience a decrease in immune system function, a decline in blood vessel functioning, chronic inflammation, and other issues. Clinical data has suggested that Lomecel-B™ may address these conditions through multiple mechanisms of action (MOA) that simultaneously target key aging-related processes.

The Company is headquartered in Miami, Florida.

Lomecel-B™

Lomecel-B™ is being evaluated in multiple clinical trials for aging-related chronic diseases and other life-threatening conditions under U.S. FDA-approved Investigational New Drug applications. Lomecel-B™ has multiple potential mechanisms of action encompassing pro-vascular, pro-regenerative, anti-inflammatory, and tissue repair and healing effects with broad potential applications across a spectrum of disease areas.

The drug is made from special living cells called Medicinal Signaling Cells (MSCs) that are isolated from fresh bone marrow tissue that has been donated by adult donors aged 18 to 45. Once the MSCs have been isolated from the fresh bone marrow through a careful selection process, the cells are culture-expanded (allowed to replicate under controlled laboratory conditions) into the billions using specialized techniques and processes. After a specific number of expansion cycles, called “passages,” the cells are harvested, separated into specific doses (e.g., 50 million cells), and cryopreserved until future use.

These cells have been shown to have characteristics that allow them to be transplanted from a donor to host without triggering a harmful immune response in the recipient, and they can be administered on an outpatient basis in as little as 40 minutes after thawing. Because of these characteristics, Lomecel-B™ is considered an “off-the-shelf” product.

In some trials, such as for Alzheimer’s disease and Aging-related Frailty, Lomecel-B™ is administered via peripheral intravenous infusion, while, in the Company’s HLHS trial, Lomecel-B™ is administered via direct injection into the heart tissue.

Market Opportunity

Longeveron estimates the potential market size for Lomecel-B™ in the treatment of HLHS to be up to $1 billion annually, globally.

U.S. patients suffering from Aging-related Frailty are estimated using U.S. Census Bureau statistics to be approximately 8.1 million. That population potentially represents a market for Lomecel-B™ of between $4 billion and $8 billion globally per year, according to Company estimates.

Additionally, the Alzheimer’s Association puts the number of Americans with that disease at 5.1 million, highlighting another potentially addressable market for Lomecel-B™, that’s worth $5 billion to $10 billion annually.

Management Team

Wa’el Hashad is CEO of Longeveron. He has more than 35 years of experience in the pharmaceutical and biotech industries. He has launched several successful brands in the U.S. and worldwide markets. Prior to joining Longeveron, he was president and CEO of Avanir Pharmaceuticals. Before Avanir, he was the chief commercial officer of Seres Therapeutics. He also has held senior leadership positions at Amgen, Boehringer Ingelheim, and Eli Lilly and Company. He holds a bachelor’s degree in pharmacy from Cairo University and an MBA from the University of Akron.

Joshua M. Hare, M.D., FACC, FAHA, is Co-Founder, Chief Science Officer and Chairman of Longeveron. He is a double board-certified cardiologist and is the founding director of the Interdisciplinary Stem Cell Institute at the University of Miami’s Miller School of Medicine. He is a recipient of the Paul Beeson Physician Faculty Scholar in Aging Research Award and is an elected member of the American Association of Physicians and The American Society for Clinical Investigation. He is also an elected Fellow of the American Heart Association. He received a bachelor’s degree from the University of Pennsylvania and his M.D. from The Johns Hopkins University School of Medicine.

Lisa Locklear is CFO at Longeveron. She previously served as the senior vice president and CFO for Avanir Pharmaceuticals. Prior to Avanir, she held senior financial roles at GSN Games, CoreLogic, Ingram Micro, the Walt Disney Company, and Price Waterhouse, with assignments in Paris and London. She holds a bachelor’s degree in plant science from the University of California, Davis, and an MBA from the University of California, Irvine. She is a licensed CPA (inactive) and is a member of the American Institute of Certified Public Accountants, the California Society of CPAs, and Financial Executives International.

Dr. Nataliya Agafonova, M.D., is the Chief Medical Officer at Longeveron. She previously served as clinical development lead, senior medical director, and product development chair at Otsuka Pharmaceuticals. Before that, she was the clinical development lead and senior medical director at Bristol-Myers Squibb. She previously held senior leadership positions at Ardea Bioscience, Biogen, Amgen, and Genzyme Corporation. She earned an M.D. from the Ukrainian National Medical University and completed her internal medicine residency at Kharkov State University Hospital in Ukraine.

Certain statements in this corporate profile that are not historical facts are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve risks and uncertainties that could cause actual results to differ materially from those anticipated by the statements made herein. Forward-looking statements are generally identifiable by the use of forward-looking terminology such as “believe,” “expects,” “may,” “looks to,” “will,” “should,” “plan,” “intend,” “on condition,” “target,” “see,” “potential,” “estimates,” “preliminary,” or “anticipates” or the negative thereof or comparable terminology, or by discussion of strategy or goals or other future events, circumstances, or effects. Factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements in this release include, but are not limited to, statements regarding the offer and sale of securities, the terms of the offering, about the ability of Longeveron’s clinical trials to demonstrate safety and efficacy of the Company’s product candidates, and other positive results; the timing and focus of the Company’s ongoing and future preclinical studies and clinical trials and the reporting of data from those studies and trials; the size of the market opportunity for the Company’s product candidates, including its estimates of the number of patients who suffer from the diseases being targeted; the success of competing therapies that are or may become available; the beneficial characteristics, safety, efficacy and therapeutic effects of the Company’s product candidates; the Company’s ability to obtain and maintain regulatory approval of its product candidates in the U.S., Japan and other jurisdictions; the Company’s plans relating to the further development of its product candidates, including additional disease states or indications it may pursue; the Company’s plans and ability to obtain or protect intellectual property rights, including extensions of existing patent terms where available and its ability to avoid infringing the intellectual property rights of others; the need to hire additional personnel and the Company’s ability to attract and retain such personnel; the Company’s estimates regarding expenses, future revenue, capital requirements and needs for additional financing; the Company’s need to raise additional capital, and the difficulties it may face in obtaining access to capital, and the dilutive impact it may have on its investors; the Company’s financial performance and ability to continue as a going concern, and the period over which it estimates its existing cash and cash equivalents will be sufficient to fund its future operating expenses and capital expenditure requirements. Additionally, Longeveron makes no assurance that any public offering of its securities as described herein will occur on the timelines, in the manner or on the terms anticipated due to numerous factors. Further information relating to factors that may impact the Company’s results and forward-looking statements are disclosed in the Company’s filings with the Securities and Exchange Commission, including Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2022, filed with the Securities and Exchange Commission on March 14, 2023 and its Quarterly Report on Form 10-Q for the second quarter of 2023 filed with the SEC on August 11, 2023. The forward-looking statements contained in this corporate profile are made as of the date of this corporate profile, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.

Investor Contact
Mike Moyer
LifeSci Advisors
Tel: 617-308-4306
Email: mmoyer@lifesciadvisors.com

Date prepared: August 31, 2023

Longeveron Inc. (NASDAQ: LGVN), closed Friday's trading session at $2.2, off by 10.2041%, on 1,644,139 volume. The average volume for the last 3 months is 8.583M and the stock's 52-week low/high is $0.7707/$37.80.

Recent News

CNS Pharmaceuticals Inc. (NASDAQ: CNSP)

The QualityStocks Daily Newsletter would like to spotlight CNS Pharmaceuticals Inc. (NASDAQ: CNSP).

New research carried out by scientists at the University of Birmingham and Newcastle University has determined that a new brain scan could decrease waiting times for diagnosis for children living with brain cancer. The most common form of brain cancer is medulloblastoma, which is further divided into four types: anaplastic or large cell medulloblastoma, medulloblastoma with extensive nodularity, classical medulloblastoma, and nodular or desmoplastic medulloblastoma. The research was funded by Cancer Research UK and Children with Cancer UK. The scientists published their findings in "eBioMedicine." As brain-cancer diagnosis improves and drug developers such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) bring to market better therapeutics, the prospects of children and adults diagnosed with various brain cancers will improve from what the situation is at the moment.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is a clinical stage biotechnology company specializing in the development of novel treatments for primary and metastatic cancers of the brain and central nervous system.

The company was founded in 2017 and is headquartered in Houston, Texas.

Organ Targeted Therapeutics

The company’s lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and incurable form of brain cancer. Berubicin also has potential to treat other central nervous system malignancies. Based on limited clinical data, Berubicin appears to be the first anthracycline to cross the blood brain barrier in the adult brain, and it was the subject of a successful Phase 1 study which found the MDT and produced efficacy data as well.

CNS holds a worldwide exclusive license to the Berubicin chemical compound. The company has acquired all requisite data and know-how from Reata Pharmaceuticals Inc. related to a completed Phase I clinical trial of Berubicin in malignant brain tumors. In this trial, 44% of patients experienced a statistically significant improvement in clinical benefit. In 2017, CNS entered into a collaboration and asset purchase agreement with Reata.

CNS intends to explore the potential of Berubicin to treat other diseases, including pancreatic and ovarian cancers and lymphoma. The company is also examining plans to develop combination therapies that include Berubicin.

CNS estimates that more than $25 million in private capital and grants were invested in Berubicin prior to the company’s $9.8 million IPO in November 2019.

CNS intends to submit an IND for Berubicin during the fourth quarter of 2020 and expects to commence a Phase II clinical trial of Berubicin for the treatment of GBM in the U.S. in Q1 2021. A sub-licensee partner was awarded a $6 million EU/Polish National Center for Research and Development grant to undertake a Phase II trial of Berubicin in adults and a first-ever Phase I trial in pediatric GBM patients in Poland in 2021.

The company’s second drug candidate, WP1244, is a novel DNA binding agent licensed from the MD Anderson Cancer Center. In preclinical studies, WP1244 proved to be 500-times more potent than the chemotherapeutic agent, daunorubicin, in inhibiting tumor cell proliferation. The company has entered into a sponsored research agreement with the MD Anderson Cancer Center to further the development of WP1244.

CNS Pharmaceuticals recently engaged U.S.-based Pharmaceutics International Inc. and Italian BSP Pharmaceuticals SpA for the production of the Berubicin drug product. The company has implemented a dual-track manufacturing strategy to mitigate COVID-19-related risks, diversify its supply chain and provide for localized availability of Berubicin. CNS has already completed synthesis of Berubicin’s active pharmaceutical ingredient (API) and has shipped the API to both manufacturers in order to prepare an injectable form of Berubicin for clinical use.

Global Brain Tumor Therapeutics Market

The high recurrence rate of malignant brain tumors is due to reappearance of focal masses, indicating that a sub-population of tumor cells in these cancers may be insensitive to current therapies and may be responsible for reinitiating tumor growth. This necessitates the development of newer drugs in the market that demonstrate greater efficacy in treating such aggressive cancers.

A global increase in neurological disorders has placed increased attention on cancers of the brain over the past decade. Neurological disorders are becoming one of the most prevalent types of disorders, due to longer life expectancy, greater exposure to infection and an increasingly sedentary lifestyle. Because few treatments for primary and metastatic cancers of the brain exist, costs are high and have acted as a restraint for the brain tumor therapeutics market.

Despite progress in surgery, radiotherapy and chemotherapeutic strategies, effective treatments for brain cancer are limited by a lack of specific therapies for the brain and the difficulty in transporting therapeutic compounds across the blood brain barrier. Therefore, there is a significant need for novel and effective therapeutic drugs and strategies that prolong survival and improve quality of life for brain tumor patients.

Several companies are making significant investments into R&D, which is expected to bring more treatment options to the market in the near future. Industry reports consistently project continued growth in the market.

One report estimates that the global brain tumor therapeutics market will reach a valuation of $2.74 billion in 2023, with the market expected to register a CAGR of 11% during the forecast period from 2018 to 2023. Another report projects that the global brain tumor therapeutics market will reach $3.4 billion by 2025, up from $2.25 billion in 2019 (http://nnw.fm/eDUjp).

Management Team

John M. Climaco is the CEO of CNS Pharmaceuticals. For 15 years, Climaco has served in leadership roles for a variety of health care companies. Recently, Climaco served as the Executive Vice President of Perma-Fix Medical S.A, where he managed the development of a novel method to produce Technitium-99. Climaco also served as President and CEO of Axial Biotech Inc., a DNA diagnostics company. In the process of taking Axial from inception to product development to commercialization, Climaco forged strategic partnerships with Medtronic, Johnson & Johnson and Smith & Nephew.

Christopher Downs, CPA, is the company’s Chief Financial Officer. Downs previously served as Interim Chief Financial Officer and Executive Vice President of InfuSystem Holdings Inc. (NYSE: INFU), a supplier of infusion services to oncologists in the United States. Downs holds a Bachelor of Science from the United States Military Academy at West Point, an MBA from Columbia Business School and a Master of Science in Accounting from the University of Houston-Clear Lake.

Dr. Donald Picker is the Chief Scientific Officer of CNS. Picker has over 35 years of drug development experience. Prior to joining CNS, Picker worked at Johnson Matthey, where he was responsible for the development of Carboplatin, one of the world’s leading cancer drugs, which was acquired by Bristol-Myers Squibb with annual sales of over $500 million. In addition, he oversaw the development of Satraplatin and Picoplatin, third-generation platinum drugs currently in late-stage clinical development.

Sandra L. Silberman, M.D., Ph.D., is the Chief Medical Officer of CNS Pharmaceuticals. Silberman is a hematologist/oncologist who earned her B.A., Sc.M. and Ph.D. from the Johns Hopkins University School of Arts and Sciences, School of Public Health and School of Medicine, respectively, and her M.D. from Cornell University Medical College. She then completed both a clinical fellowship in hematology/oncology and a research fellowship in tumor immunology at the Brigham & Women’s Hospital and the Dana Farber Cancer Institute in Boston, Massachusetts. Silberman has played key roles in the development of many drugs, including Gleevec(TM), for which she led the global clinical development at Novartis. Silberman advanced several original, proprietary compounds into Phases I through III during her work with leading biopharmaceutical companies, including Bristol-Myers Squibb, AstraZeneca, Imclone and Roche.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), closed Friday's trading session at $1.98, off by 7.0423%, on 146,693 volume. The average volume for the last 3 months is 212,163 and the stock's 52-week low/high is $1.98/$6875.00.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Chinese technology company Huawei has debuted revolutionary renewable-energy solutions with the potential to redefine the global photovoltaic (PV) solar as well as energy-storage sectors. Steven Zheng, president of Huawei's Utility Smart ESS Business, recently unveiled the renewable energy sector's first ever Cell-to-Grid Smart String & Grid-Forming ESS Platform. Set on accelerating the world's journey to carbon neutrality and providing value to industries and customers, Huawei created the Smart Renewable Energy Generator by integrating energy-storage management technologies, thermal management, digital and power electronics. The company harnessed all the technological advancements it has made in grid forming technologies, energy-storage systems (ESSs) and PV modules to aid the development of power systems that run on renewable energy. In the meantime, Huawei has collaborated with several projects including a Saudi Arabian microgrid, string grid-forming energy-storage plants in its home country, and the Kela PV Project in Sichuan as part of its efforts to boost green-energy innovation and lead the pack in the race to develop high-quality, autonomous power plants of utility scale. The revolutionary system debuted by Huawei comes at a time when other enterprises such as Correlate Energy Corp. (OTCQB: CIPI) are also investing heavily in bringing new solutions to the clean-energy space so that the transition to green energy happens cost effectively, not only in the developed world but also in less-developed communities.

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Friday's trading session at $0.5, off by 22.4806%, on 106,174 volume. The average volume for the last 3 months is 6,204 and the stock's 52-week low/high is $0.4121/$2.35.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.